Trial Site Detail
Drug: |
Guadecitabine |
|||
|---|---|---|---|---|
Trial: |
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), In Children And Adults With Wild Type GIST, Pheochromocytoma And Paraganglioma Associated With Succinate Dehydrogenase Deficiency And HLRCC-Associated Kidney Cancer |
|||
| Conditions: | SDH- GIST | |||
Trial Status: |
Completed |
|||
National Cancer InstituteBuilding 10, Room 4-3760 10 Center Drive |
Principal Investigator: |
John W. Glod, MD |
|---|---|
Contact: |
Melissa M Spencer, R.N. 301-451-9036 melissa.spencer@nih.gov |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
National Cancer Institute Website: |
http://www.cc.nih.gov/index.html |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.